Horizon therapeutics public limited company (HZNP)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Net sales

355,909

363,545

335,466

320,647

280,371

355,543

325,311

302,835

223,881

274,219

271,646

289,507

220,859

310,350

208,702

257,378

204,690

244,538

226,544

172,821

113,141

103,841

75,126

66,062

51,926

30,080

24,112

11,131

8,693

5,959

6,521

3,841

2,523

3,526

273

1,335

1,793

-

-

Cost of goods sold

97,416

94,921

89,949

89,163

88,142

98,599

91,077

91,337

110,288

98,585

125,517

130,150

139,116

148,481

85,161

81,126

77,233

67,573

61,250

61,826

28,853

32,680

13,644

24,810

7,619

5,255

3,207

2,394

3,769

3,143

3,810

2,855

2,067

2,075

1,249

2,104

1,839

737

2,132

Sale of goods

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,556

2,854

-

233

1,294

1,763

689

1,657

Contract revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

52

53

-

40

41

30

-

-

Gross sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,698

-

7,311

4,608

2,907

3,538

273

1,335

1,793

689

1,657

Sales discounts and allowances

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,005

-

790

767

384

-

-

-

-

-

-

Gross profit

258,493

268,624

245,517

231,484

192,229

256,944

234,234

211,498

113,593

175,634

146,129

159,357

81,743

161,869

123,541

176,252

127,457

176,965

165,294

110,995

84,288

71,161

61,482

41,252

44,307

24,825

20,905

8,737

4,924

2,816

2,711

986

456

1,451

-976

-769

-46

-48

-475

OPERATING EXPENSES:
Research and development

27,209

28,589

24,572

28,314

21,725

19,721

21,169

24,265

17,645

30,910

17,928

163,101

13,061

23,961

12,814

11,210

12,722

13,689

13,073

8,922

6,181

6,859

4,223

3,545

2,833

2,899

2,154

2,833

2,198

4,739

3,796

4,233

4,069

3,821

5,346

3,462

2,729

5,721

4,292

Selling, general and administrative

247,775

185,391

172,326

167,095

172,299

174,627

161,585

176,674

179,599

167,423

153,952

159,653

174,065

195,485

132,049

133,575

141,939

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss (gain) on sale of assets

-

-

-

-10,963

-

-

12,303

-

-

-

-

5,856

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of long-lived assets

-

-

-

-

-

10,846

1,603

0

33,647

-

-

22,270

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales and marketing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

51,973

58,056

47,063

33,344

31,111

27,126

28,695

20,120

15,621

16,526

16,328

15,095

12,951

10,543

10,972

12,887

5,141

1,169

1,117

1,955

1,397

General and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

54,516

77,190

26,280

21,975

38,109

17,681

11,192

7,568

5,874

5,182

4,942

5,008

4,678

4,555

5,203

4,370

4,192

3,348

3,098

3,880

5,795

Total operating expenses

274,984

213,949

196,898

206,372

194,024

174,474

172,054

200,939

230,891

198,295

171,880

345,024

187,126

290,706

144,863

144,785

154,661

138,916

119,562

144,168

79,524

62,178

73,443

48,352

42,720

30,587

23,649

24,541

23,468

24,842

21,425

19,331

20,244

90,699

14,679

7,979

6,944

11,556

11,484

Operating loss

-16,491

54,675

48,619

25,112

-1,795

82,470

62,180

10,559

-117,298

-22,661

-25,751

-185,667

-105,383

-128,837

-21,322

31,467

-27,204

38,049

45,732

-33,173

4,764

8,983

-11,961

-7,100

1,587

-5,762

-2,744

-15,804

-18,544

-22,026

-18,714

-18,345

-19,788

-89,248

-15,655

-8,748

-6,990

-11,604

-11,959

OTHER EXPENSE, NET:
Interest expense, net

-17,344

-17,098

-20,428

-22,033

-27,530

-29,771

-30,437

-31,030

-30,454

-31,226

-31,706

-31,608

-31,983

-28,858

-19,066

-19,228

-19,458

-20,120

-20,300

-19,448

-10,032

-27,046

-5,194

4,207

4,207

-23,420

3,601

3,442

3,603

471

3,339

3,191

4,551

819

995

3,185

1,285

1,031

523

Loss on debt extinguishment

-

0

-41,371

-11,878

-5,586

-

-

-

-

-445

0

0

-533

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on divestiture

-

-

-

-

-

-

-

-

-

-

112

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12

Foreign exchange gain (loss)

776

58

-40

76

-61

-112

35

-5

-110

-427

275

151

-259

-739

-108

15

-173

-227

-86

-87

-837

-829

-2,754

-284

-38

539

1,118

454

-905

801

588

-1,401

501

-797

-758

110

422

164

41

Loss on induced conversion of debt and debt extinguishment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-67,080

-10,544

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Bargain purchase gain

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22,171

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19,326

Loss on derivative fair value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

10,965

204,030

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Other income, net

442

-751

890

-1,272

189

7

337

346

151

167

280

-35

35

-142

6,879

-26

-14

-132

-90

-9,078

-991

-3,010

-3,241

-4,333

-667

-

-

0

-

0

0

-4

-52

-

0

-

-

-

-

Total other expense, net

-16,126

-17,791

-60,949

-35,107

-32,988

-29,876

-30,065

-30,689

-30,413

-29,934

-31,039

-25,636

-32,740

-29,739

-12,295

-19,239

-19,645

-49,511

-20,476

-95,693

-22,404

-43,447

10,982

-19,789

-208,942

-97,293

-2,483

-2,988

-4,508

-2,643

-2,751

-4,596

-4,102

-1,616

-1,753

-3,075

-863

-

-

Loss before benefit for income taxes

-32,617

36,884

-12,330

-9,995

-34,783

52,594

32,115

-20,130

-147,711

-52,595

-56,790

-211,303

-138,123

-158,576

-33,617

12,228

-46,849

-11,462

25,256

-128,866

-17,640

-34,464

-979

-26,889

-207,355

-103,055

-5,227

-18,792

-23,052

-24,669

-21,465

-22,941

-23,890

-90,864

-17,408

-11,823

-7,853

-12,471

6,897

Benefit for income taxes

-19,000

-555,844

-30,600

-4,900

-1,900

-48,997

-1,300

4,600

945

-66,547

7,181

-1,767

-47,553

-29,305

-27,747

-2,756

-1,443

-35,456

21,979

-160,680

1,913

-2,817

-3,042

880

-1,105

-154

265

-351

-881

-336

-4,512

-159

-164

-14,138

-177

-186

-182

16

13

Net loss

-13,591

592,769

18,234

-5,120

-32,863

101,646

33,381

-24,751

-148,656

13,952

-63,971

-209,536

-90,570

-129,271

-5,870

14,984

-45,406

23,994

3,277

31,814

-19,553

-31,647

2,063

-27,769

-206,250

-102,901

-5,492

-18,441

-22,171

-24,333

-16,953

-22,782

-23,726

-76,726

-17,231

-11,637

-7,671

-12,487

6,884

Net loss per ordinary share—basic and diluted

-0.07

-

-

-0.03

-0.19

-

-

-0.15

-0.90

-

-

-1.29

-0.56

-

-0.04

-

-0.28

-

-

-

-0.16

-

-

-

-3.07

-

-

-0.29

-0.36

-0.13

-0.47

-0.68

-0.98

1.65

-1.30

-7.78

-5.13

-8.38

-

Weighted average ordinary shares outstanding—basic and diluted

190,072

-

-

185,327

172,789

-

-

165,536

164,549

-

-

162,931

161,972

-

161,038

-

159,904

-

-

-

125,650

-

-

-

67,138,463

-

-

62,872

61,939

61,680

35,972

33,715

24,116

19,813

13,256

1,496

1,493

1,490

-

Net income (loss) per ordinary share—basic

-

-

0.10

-

-

-

0.20

-

-

-

-0.39

-

-

-

-

0.09

-

-

0.02

0.21

-

-

0.03

-0.38

-

-

-0.08

-

-

-

-

-

-

-

-

-

-

-

4.62

Weighted average ordinary shares outstanding—basic

-

-

186,470

-

-

-

167,047

-

-

-

163,447

-

-

-

-

160,468

-

-

159,035

150,771

-

-

78,392

73,384

-

-

64,645

-

-

-

-

-

-

-

-

-

-

-

1,490

Net income (loss) per ordinary share—diluted

-

-

0.09

-

-

-

0.19

-

-

-

-0.39

-

-

-

-

0.09

-

-

0.02

0.20

-

-

0.02

-0.38

-

-

-0.08

-

-

-

-

-

-

-

-

-

-

-

0.56

Weighted average ordinary shares outstanding—diluted

-

-

194,171

-

-

-

172,485

-

-

-

163,447

-

-

-

-

163,920

-

-

166,830

159,797

-

-

85,687

73,384

-

-

64,645

-

-

-

-

-

-

-

-

-

-

-

12,363

OTHER COMPREHENSIVE LOSS, NET OF TAX
Foreign currency translation adjustments

-325

570

-809

344

-487

-259

-133

-897

463

1,322

-209

626

328

-106

-110

161

-247

153

-48

-257

1,864

-1,167

-654

-144

5

371

993

402

-797

-328

483

-832

1,093

-4,753

-5,977

2,348

6,823

-

-

Pension remeasurements

-

-

-

-

-

-

-

-289

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized loss on long-term investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-29,400

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other comprehensive loss

-325

570

-809

344

-487

-262

-133

-608

463

1,358

-209

626

328

-239

-110

161

-247

29,553

-29,448

-257

1,864

-1,167

-654

-144

5

371

993

402

-797

-328

483

-832

1,093

-4,753

-5,977

2,348

6,823

-

-

Comprehensive loss

-13,916

593,339

17,425

-4,776

-33,350

101,384

33,248

-25,359

-148,193

15,310

-64,180

-208,910

-90,242

-129,510

-5,980

15,145

-45,653

53,547

-26,171

31,557

-17,689

-32,814

1,409

-27,913

-206,245

-102,530

-4,499

-18,039

-22,968

-24,661

-16,470

-23,614

-22,633

-81,479

-23,208

-9,289

-848

-

-